Financhill
Back

Charles River Laboratories International Vs. Arbutus Biopharma Industry Stock Comparison

Sell
43

CRL
Charles River Laboratories International

Last Price:
195.80
Seasonality Move:
9.91%
Sell
37

ABUS
Arbutus Biopharma

Last Price:
3.51
Seasonality Move:
24.22%
Sell
43
Charles River Laboratories International (CRL) is a Sell

Is Charles River Laboratories International a Buy, Sell or Hold?

  • The current Charles River Laboratories International [CRL] share price is $195.77. The Score for CRL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CRL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.51. The Score for ABUS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRL Stock Price Chart

What is Charles River Laboratories International's stock price today?

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight buying pressure.

CRL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 50.6 Buy
Chaikin Money Flow: 11698 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (180.82 - 205.92) Buy
Bollinger Bands (100): (187.27 - 217.23) Sell

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 34.97 Sell
Chaikin Money Flow: 429896 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.59 - 4.01) Sell
Bollinger Bands (100): (3.58 - 4.12) Sell

CRL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 192.83 Buy
20-day SMA: 195.09 Buy
50-day SMA: 195.01 Buy
200-day SMA: 219.12 Sell
8-day EMA: 194.21 Buy
20-day EMA: 195.09 Buy
50-day EMA: 196.22 Sell
200-day EMA: 208.31 Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.54 Sell
20-day SMA: 3.74 Sell
50-day SMA: 3.89 Sell
200-day SMA: 3.38 Buy
8-day EMA: 3.55 Sell
20-day EMA: 3.69 Sell
50-day EMA: 3.8 Sell
200-day EMA: 3.43 Buy

Charles River Laboratories International Earnings Growth & CRL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.13 per share.

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

Charles River Laboratories International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):